Researchers Develop Blood Test To Measure Glycan Generated By Pancreatic Cancers That Generally Do Not Respond To Chemotherapy
November 23, 2020
Healio (11/20, Byrne) reported researchers “developed and evaluated a blood test that measures concentrations of a glycan called sTRA,” which “is generated by pancreatic cancers that generally do not respond to chemotherapy.” The findings were published i...
